F Dx Advisors, Inc. Abbott Laboratories Transaction History

F Dx Advisors, Inc.

$367 Million
Q3 2024

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 03, 2024	SELL	$109.52 - $120.96 $713,194 - $787,691	-6,512 Reduced 12.86%	44,136 $5.02 Million
Q4 2023 Feb 12, 2024	SELL	$90.19 - $110.4 $554,217 - $678,408	-6,145 Reduced 10.82%	50,648 $5.58 Million
Q3 2023 Nov 02, 2023	SELL	$95.53 - $114.62 $5.98 Million - $7.17 Million	-62,580 Reduced 52.42%	56,793 $5.5 Million
Q2 2023 Jul 17, 2023	SELL	$100.78 - $112.29 $26.1 Million - $29.1 Million	-259,428 Reduced 68.49%	119,373 $13 Million
Q4 2022 Feb 09, 2023	SELL	$95.06 - $111.52 $105,896 - $124,233	-1,114 Reduced 0.29%	378,801 $41.6 Million
Q3 2022 Nov 10, 2022	SELL	$96.76 - $112.03 $7.36 Million - $8.53 Million	-76,112 Reduced 16.69%	379,915 $36.8 Million
Q2 2022 Aug 03, 2022	SELL	$102.07 - $123.37 $19.3 Million - $23.3 Million	-188,610 Reduced 29.26%	456,027 $49.5 Million
Q1 2022 May 03, 2022	BUY	$114.02 - $139.04 $105,810 - $129,029	928 Added 0.14%	644,637 $76.3 Million
Q4 2021 Feb 01, 2022	BUY	$115.53 - $141.46 $4.3 Million - $5.27 Million	37,255 Added 6.14%	643,709 $90.6 Million
Q3 2021 Oct 08, 2021	BUY	$116.66 - $129.06 $3.33 Million - $3.68 Million	28,537 Added 4.94%	606,454 $71.6 Million
Q2 2021 Aug 05, 2021	BUY	$105.79 - $124.53 $3.84 Million - $4.52 Million	36,293 Added 6.7%	577,917 $67 Million
Q1 2021 Apr 14, 2021	BUY	$108.84 - $128.23 $51.9 Million - $61.1 Million	476,716 Added 734.45%	541,624 $64.9 Million
Q1 2021 Apr 13, 2021	SELL	$108.84 - $128.23 $47.6 Million - $56.1 Million	-437,772 Reduced 87.09%	64,908 $7.78 Million
Q4 2020 Feb 08, 2021	BUY	$105.0 - $114.42 $1.03 Million - $1.12 Million	9,828 Added 1.99%	502,680 $55 Million
Q3 2020 Nov 12, 2020	BUY	$91.64 - $111.29 $4.33 Million - $5.26 Million	47,220 Added 10.6%	492,852 $53.6 Million
Q2 2020 Jul 22, 2020	BUY	$76.57 - $98.0 $1.42 Million - $1.82 Million	18,594 Added 4.35%	445,632 $40.7 Million
Q1 2020 May 22, 2020	BUY	$62.82 - $91.86 $25.4 Million - $37.1 Million	404,140 Added 1764.96%	427,038 $33.7 Million
Q1 2020 May 13, 2020	SELL	$62.82 - $91.86 $13.1 Million - $19.2 Million	-208,876 Reduced 90.12%	22,898 $996,000
Q4 2019 Feb 12, 2020	BUY	$78.51 - $87.4 $14.9 Million - $16.6 Million	189,408 Added 447.08%	231,774 $20.1 Million
Q3 2019 Nov 07, 2019	SELL	$81.84 - $88.74 $127,424 - $138,168	-1,557 Reduced 3.54%	42,366 $3.55 Million
Q2 2019 Jul 19, 2019	SELL	$72.88 - $85.0 $313,967 - $366,180	-4,308 Reduced 8.93%	43,923 $3.69 Million
Q1 2019 May 14, 2019	SELL	$66.22 - $80.06 $580,219 - $701,485	-8,762 Reduced 15.37%	48,231 $3.86 Million
Q4 2018 Apr 29, 2019	SELL	$65.56 - $74.27 $3.43 Million - $3.89 Million	-52,358 Reduced 47.88%	56,993 $4.12 Million
Q4 2018 Feb 07, 2019	BUY	$65.56 - $74.27 $2.6 Million - $2.94 Million	39,602 Added 56.78%	109,351 $7.91 Million
Q3 2018 Nov 13, 2018	BUY	$60.81 - $73.36 $168,261 - $202,987	2,767 Added 4.13%	69,749 $5.12 Million
Q2 2018 Aug 08, 2018	BUY	$57.57 - $63.54 $710,644 - $784,337	12,344 Added 22.59%	66,982 $4.09 Million
Q1 2018 May 02, 2018	BUY	$56.27 - $63.62 $261,317 - $295,451	4,644 Added 9.29%	54,638 $3.27 Million
Q4 2017 Feb 09, 2018	SELL	$53.68 - $57.47 $523,916 - $560,907	-9,760 Reduced 16.33%	49,994 $2.85 Million
Q3 2017 Nov 03, 2017	BUY	$48.06 - $53.64 $7,401 - $8,260	154 Added 0.26%	59,754 $3.19 Million
Q2 2017 Aug 11, 2017	BUY	N/A	59,600	59,600 $2.9 Million

Others Institutions Holding ABT

# of Institutions

3,185

Shares Held

1.3B

Call Options Held

8.74M

Put Options Held

8.08M

Vanguard Group Inc Valley Forge, PA

168M
Shares

$20 Billion
0.35% of portfolio
Black Rock Inc. New York, NY

131M
Shares

$15.6 Billion
0.31% of portfolio
State Street Corp Boston, MA

76.7M
Shares

$9.13 Billion
0.36% of portfolio
Capital International Investors Los Angeles, CA

65.7M
Shares

$7.82 Billion
1.49% of portfolio
Capital Research Global Investors Los Angeles, CA

53.3M
Shares

$6.34 Billion
1.31% of portfolio

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $208B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of F Dx Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on F Dx Advisors, Inc. with notifications on news.

Account